Literature DB >> 30917059

Neurophysiology of the brain stem in Parkinson's disease.

Cecilia Bove1, R Alberto Travagli1.   

Abstract

Parkinson's disease (PD) is predominantly idiopathic in origin, and a large body of evidence indicates that gastrointestinal (GI) dysfunctions are a significant comorbid clinical feature; these dysfunctions include dysphagia, nausea, delayed gastric emptying, and severe constipation, all of which occur commonly before the onset of the well-known motor symptoms of PD. Based on a distinct distribution pattern of Lewy bodies (LB) in the enteric nervous system (ENS) and in the preganglionic neurons of the dorsal motor nucleus of the vagus (DMV), and together with the early onset of GI symptoms, it was suggested that idiopathic PD begins in the ENS and spreads to the central nervous system (CNS), reaching the DMV and the substantia nigra pars compacta (SNpc). These two areas are connected by a recently discovered monosynaptic nigro-vagal pathway, which is dysfunctional in rodent models of PD. An alternative hypothesis downplays the role of LB transport through the vagus nerve and proposes that PD pathology is governed by regional or cell-restricted factors as the leading cause of nigral neuronal degeneration. The purpose of this brief review is to summarize the neuronal electrophysiological findings in the SNpc and DMV in PD.

Entities:  

Keywords:  brain stem; neurodegenerative disorders; vagus; whole cell patch clamp

Mesh:

Substances:

Year:  2019        PMID: 30917059      PMCID: PMC6589717          DOI: 10.1152/jn.00056.2019

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  135 in total

1.  Endogenous L-dopa in the rat dorsal vagal complex: an immunocytochemical study by light and electron microscopy.

Authors:  F Tison; N Mons; S Rouet-Karama; M Geffard; P Henry
Journal:  Brain Res       Date:  1989-09-18       Impact factor: 3.252

Review 2.  Cell signaling and neuronal death.

Authors:  Makoto R Hara; Solomon H Snyder
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.

Authors:  M G Murer; G Dziewczapolski; L B Menalled; M C García; Y Agid; O Gershanik; R Raisman-Vozari
Journal:  Ann Neurol       Date:  1998-05       Impact factor: 10.422

Review 4.  Dyskinesias and levodopa therapy: why wait?

Authors:  Michele Matarazzo; Alexandra Perez-Soriano; A Jon Stoessl
Journal:  J Neural Transm (Vienna)       Date:  2018-02-10       Impact factor: 3.575

Review 5.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2013-04-15       Impact factor: 10.338

Review 6.  Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models.

Authors:  C Pellegrini; R Colucci; L Antonioli; E Barocelli; V Ballabeni; N Bernardini; C Blandizzi; W J de Jonge; M Fornai
Journal:  Neurogastroenterol Motil       Date:  2016-09-09       Impact factor: 3.598

7.  A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation.

Authors:  I Marey-Semper; M Gelman; M Lévi-Strauss
Journal:  J Neurosci       Date:  1995-09       Impact factor: 6.167

Review 8.  Calcium homeostasis, selective vulnerability and Parkinson's disease.

Authors:  C Savio Chan; Tracy S Gertler; D James Surmeier
Journal:  Trends Neurosci       Date:  2009-03-21       Impact factor: 13.837

9.  Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.

Authors:  Stephanie Janezic; Sarah Threlfell; Paul D Dodson; Megan J Dowie; Tonya N Taylor; Dawid Potgieter; Laura Parkkinen; Steven L Senior; Sabina Anwar; Brent Ryan; Thierry Deltheil; Polina Kosillo; Milena Cioroch; Katharina Wagner; Olaf Ansorge; David M Bannerman; J Paul Bolam; Peter J Magill; Stephanie J Cragg; Richard Wade-Martins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

10.  Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.

Authors:  Sarah Berk; Brittany L Greco; Kevin Biglan; Catherine M Kopil; Robert G Holloway; Claire Meunier; Tanya Simuni
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

View more
  6 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism.

Authors:  C Bove; F H Coleman; R A Travagli
Journal:  Neuroscience       Date:  2019-09-03       Impact factor: 3.590

Review 3.  The Microbiota-Gut-Brain Axis: From Motility to Mood.

Authors:  Kara G Margolis; John F Cryan; Emeran A Mayer
Journal:  Gastroenterology       Date:  2021-01-22       Impact factor: 22.682

Review 4.  Central Neurocircuits Regulating Food Intake in Response to Gut Inputs-Preclinical Evidence.

Authors:  Kirsteen N Browning; Kaitlin E Carson
Journal:  Nutrients       Date:  2021-03-11       Impact factor: 5.717

Review 5.  Lewy body disease or diseases with Lewy bodies?

Authors:  Kateřina Menšíková; Radoslav Matěj; Carlo Colosimo; Raymond Rosales; Lucie Tučková; Jiří Ehrmann; Dominik Hraboš; Kristýna Kolaříková; Radek Vodička; Radek Vrtěl; Martin Procházka; Martin Nevrlý; Michaela Kaiserová; Sandra Kurčová; Pavel Otruba; Petr Kaňovský
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

6.  Environmentally Toxic Solid Nanoparticles in Noradrenergic and Dopaminergic Nuclei and Cerebellum of Metropolitan Mexico City Children and Young Adults with Neural Quadruple Misfolded Protein Pathologies and High Exposures to Nano Particulate Matter.

Authors:  Lilian Calderón-Garcidueñas; Angélica González-Maciel; Rafael Reynoso-Robles; Héctor G Silva-Pereyra; Ricardo Torres-Jardón; Rafael Brito-Aguilar; Alberto Ayala; Elijah W Stommel; Ricardo Delgado-Chávez
Journal:  Toxics       Date:  2022-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.